Grifols is strongly committed to responsible business practices, transparency and accountability.
Here you will find a comprehensive set of resources – including our Integrated and Sustainability Annual Reports, corporate policies and thematic disclosures – that reflect our efforts to care for people and the planet while creating long-term value.
These publications provide insights into our sustainability strategy, governance practices, human rights commitments, climate-related risk management, and ethical supply chain standards. They are designed to inform and engage our stakeholders: employees, patients, donors, healthcare professionals, scientists, partners and society as a whole.
2025 Integrated and Sustainability Annual Report
A comprehensive overview of our financial and non-financial performance, prepared in accordance with the EU Corporate Sustainability Reporting Directive (CSRD), Spanish Law 11/2018 on non-financial information and diversity, and leading international standards such as GRI, SASB and other relevant voluntary indicators.
Executive Summary of the Integrated and Sustainability Annual Report
Summarizes our 2024 sustainability efforts.
Sustainability Reports Archive
Human Rights Due Diligence Report 2023
Our latest report reflects our ongoing commitment to uphold and respect human rights across our global operations. It outlines our efforts to identify, prevent and mitigate human rights risks to workers, communities and stakeholders, ensuring that we operate not just in compliance with legal frameworks, but also in alignment with our core values.
Modern Slavery & Supply Chain Transparency Statement
This statement outlines our strong commitment to preventing modern slavery and ensuring transparency in our supply chain.
Risks and Opportunities Management Related to Climate Change
This document aims to outline the methodology and results obtained after analyzing and evaluating the climate-related risks and opportunities associated with Grifols' activities.
Corporate Codes & Policies
Here you will find the most relevant Grifols corporate codes & policies, guiding our actions as it relates to a variety of topics.
Approved at the Board of Directors' meeting held on 11 December 2020.
Approved at the Board of Directors' meeting held on 22 October 2024.
Its update has been approved at the Board of Directors' meeting held on 17 December 2024.
Approved at the Board of Directors' meeting held on 11 December 2020.
The last amendment was approved by the Board of Directors at its meeting held on 14 November 2025.
Its update has been approved at the Board of Directors' meeting held on 3 May 2024.
Approved by the Board of Directors in its meeting held on 10 December 2015.
Approved at the Board of Directors’ meeting held on 19 October 2023.
Approved at the Board of Directors' meeting held on 11 December 2020.
Approved at the Board of Directors’ meeting held on 18 December 2025
Approved at the Board of Directors' meeting held on 18 December 2023.
The last amendment was approved by the Board of Directors at its meeting held on 14 November 2025.
Approved at the Board of Directors' meeting held on 23 February 2023.
Approved at the Board of Directors' meeting held on 25 February 2022.
Approved at the Board of Directors' meeting held on 25 February 2022.
Approved at the Board of Directors' meeting held on 23 February 2023.
Approved at the Board of Directors' meeting held on April 17, 2024.
Our sustainability efforts are internationally recognized
Latest news
Grifols strengthens its position among the world’s most sustainable biotechnology companies after improving its Dow Jones Best-in-Class score
Living with primary immunodeficiencies: the critical role of emotional support
Grifols brings together companies and organizations to address the challenges of employment for people with disabilities
Our commitment to sustainability
Grifols' longstanding commitment to people and the planet entails helping society on all fronts by strengthening our positive social, economic and environmental impacts.